Business Standard

Anuh Pharma Share Price

Know More
Stock not traded

233.35-0.10 (-0.04%)

12:00 AM,12th Apr 2024

BSE : 506260


Sector : Health care

ISIN Code : INE489G01022

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 12 2024 | 12:00 AM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)

Face Value


52-WK High


52-WK High Date

Invalid date

52-WK Low


52-WK Low Date

Invalid date

All Time High


All Time High Date

Invalid date

All Time Low


All Time Low Date

Invalid date

Anuh Pharma Ltd

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of Bulk drugs and chemicals Their products are antibiotics erythromycin salts chloramphenicol and other chemicals. The company is part of the SK Group.Anuh Pharma Ltd was incorporated on February 19 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.The business headquarters of the firm is located in the commercial capital of India Mumbai. The company is a recognized export house and exports their products to Mexico Brazil Iran Bangladesh Colombia Germany Africa Singapore and several other countries.During the year 2006-07 the company commissioned the new plant with all latest modern techniques and facilities. Thus the production capacity of Antibiotics increased from 400000 Kg to 600000 Kg.During the year 2008-09 the company completed the on-going expansion of their plant thus they increased the installed capacity by 150 MT per annum. In September 2008 they expanded unit started commercial production.In January 2010 the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.In April 2010 the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.In June 2010 the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.The erection of a new plant for manufacture of drug intermediates was completed during the year 2010-11 and it got commissioned towards end of February 2011. In 2012 it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape Navi Mumbai & got DSIR approval. In 2014 it got approval from COFEPRIS - Mexico for Erythromycin Estolate Erythromycin Stearate Erythromycin Ethyl Succinate. In 2015 it received approval of WHO - PQ for Sulfadoxine.In March 2019 the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It received CEP for Ambroxol Hydrochloride from EDQM in 2022.

Anuh Pharma Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 5
Latest Dividend (%)40.00
Latest Dividend Date 11 Aug 2023
Dividend Yield (%) 0.86
Book Value Share (₹) [S]51.23
P/B Ratio (₹) [S]4.55
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.00 148 0.03

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-6.68%%0.000.03%
1 Month11.62%%0.780.82%
3 Month40.11%%2.312.85%
6 Month81.31%%11.8013.77%
1 Year163.82%%22.9426.43%
3 Year115.37%%55.0557.36%

Company Info

Company Information

Vice Chairman : Bipin N Shah

Non-Exec & Non-Independent Dir : Bharat N Shah

Non-Exec. & Independent Dir. : Arun L Todarwal

Non-Exec & Non-Independent Dir : Samir J Shah

Non-Exec & Non-Independent Dir : Ketan L Shah

Joint Managing Director : Ritesh B Shah

Joint Managing Director : Vivek B Shah

Chairman & Independent Directo : Jasvantlal Shah

Non-Exec & Non-Independent Dir : Mita Dixit

Non-Exec. & Independent Dir. : Harmanbhai Tulsibhai Patel

Non-Exec. & Independent Dir. : Sandeep M Joshi

Independent Director : Pradeep Thakur

Independent Director : Siddharth Shah

Independent Director : Gaurav Shah

Company Sec. & Compli. Officer : Manan Jayesh Vadhan

Registered Office: 3-A Shivsagar Estate, North Wing Dr A B Road Worli,Mumbai,Maharashtra-400018 Ph: 91-22-6622 7575